Our new ad — "PBM Career Day" — highlights the position PBMs have carved out for themselves as drug middlemen and their illogical, confusing role in health care. It's part of our #FinishTheFight campaign pushing the public to demand change and policymakers to finalize #PBMreform.
Hmm: New @AEI study estimates huge #GrossToNetBubble for GLP-1 #drugs. Net prices far below list prices due to #PBM#rebates & manuf copay support 👇
Perhaps economic impact has been overestimated?
Full report: https://t.co/hYaaFidp9A
Today, Oklahoma Insurance Commissioner @glen_mulready announced the filing of an administrative action against CVS/Caremark that outlines alleged violations of the Patient’s Right to Pharmacy Choice Act.
Full release: https://t.co/hTi5NFjPGG
#PBM#insurance#okl...
Three PBMs use a little-known company in Switzerland to help fix prices and fatten their profits —and jacked-up insulin prices is a side effect.
Our new lawsuit is the cure. https://t.co/bktEvaUJLG
"The short story is Express Scripts is cutting revenue to partners so significantly that any independent pharmacist who accepts Express Scripts customers - which can be up to half of all customers depending on the region - will now lose money."
#PBMs
https://t.co/6YsXqFXvOq
Warped Incentives Update: The Gross-to-Net Bubble Exceeded $200 Billion in 2021
Major components of #GrossToNetBubble for brand-name drugs below 👇
Details here: https://t.co/uAStxsnvLQ
#PBM#rebate#SpongeBob
A new NCPA analysis compares premiums for drug programs in states that have regulated PBMs to the national average. We found slower growth – and in some cases reductions – after lawmakers enacted laws PBM lobbyists warned would send them skyrocketing. https://t.co/9dkKLHYbJt
There's still time left to melt the phones! If you haven't already, contact your senators' offices and urge that a policy fix to #EndDIR is included in the final Build Back Better Act: https://t.co/N2GXRC3HOA The time to act is now.
There's still time left to melt the phones! If you haven't already, contact your senators' offices and urge that a policy fix to #EndDIR is included in the final Build Back Better Act: https://t.co/N2GXRC3HOA The time to act is now.
As the Biden team expands the supply of Covid vaccine, the challenge will continue to be standing up delivery sites fast; that can handle the volume. The channel that's able to quickly absorb massive volume are the pharmacies. We need to get pharmacists fully in the game.
The PBM lobby on Monday withdrew its challenge to Oklahoma’s authority to regulate PBMs while the PCMA v. Mulready case is pending, a development applauded by NCPA and @OkPharmAssoc. It’s time for Oklahomans to decide how to protect patients and local biz: https://t.co/WYImUEE3ni
💊New episode!💊
Chris Schiller of @OkPharmAssoc & I discuss how HB2632 went into law to reel in #PBMs while increasing patient choice of pharmacy services
Lot of great political discussion here for #pharmacists!
@Commpharmacy#TwitteRx#RxTwitter
https://t.co/8qypkBkFNu
#fiduciarychallenge My attempt at the PPOk Fiduciary Responsibilty Challenge. I challenge Chris Schiller, Bill Moore, and Jathan Coburn to put their money where their mouth is. Thanks to @daredprice I did.